Report cover image

Global Monoclonal Antibodies for Plaque Psoriasis Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 02, 2025
Length 102 Pages
SKU # APRC20102982

Description

Summary

According to APO Research, The global Monoclonal Antibodies for Plaque Psoriasis market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Monoclonal Antibodies for Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Monoclonal Antibodies for Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Monoclonal Antibodies for Plaque Psoriasis is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Monoclonal Antibodies for Plaque Psoriasis include AbbVie, Inc., Almirall SA, Bausch Health Cos., Inc, Biocon Ltd., Janssen Biotech, Inc., Sun Pharmaceutical Industries Ltd., UCB, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd and Eli Lilly & Co., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Monoclonal Antibodies for Plaque Psoriasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoclonal Antibodies for Plaque Psoriasis.

The Monoclonal Antibodies for Plaque Psoriasis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Monoclonal Antibodies for Plaque Psoriasis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Monoclonal Antibodies for Plaque Psoriasis Segment by Company

AbbVie, Inc.
Almirall SA
Bausch Health Cos., Inc
Biocon Ltd.
Janssen Biotech, Inc.
Sun Pharmaceutical Industries Ltd.
UCB, Inc.
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Eli Lilly & Co.
Novartis AG
Chongqing Genrix Biopharmaceutical Co., Ltd

Monoclonal Antibodies for Plaque Psoriasis Segment by Type

5-100 mg/mL
100-200 mg/mL

Monoclonal Antibodies for Plaque Psoriasis Segment by Application

Hospital
Clinic
Others

Monoclonal Antibodies for Plaque Psoriasis Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Antibodies for Plaque Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Antibodies for Plaque Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Antibodies for Plaque Psoriasis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Monoclonal Antibodies for Plaque Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Monoclonal Antibodies for Plaque Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

102 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Monoclonal Antibodies for Plaque Psoriasis Sales Estimates and Forecasts (2020-2031)
1.3 Monoclonal Antibodies for Plaque Psoriasis Market by Type
1.3.1 5-100 mg/mL
1.3.2 100-200 mg/mL
1.4 Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Type
1.4.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size Overview by Type (2020-2031)
1.4.2 Global Monoclonal Antibodies for Plaque Psoriasis Historic Market Size Review by Type (2020-2025)
1.4.3 Global Monoclonal Antibodies for Plaque Psoriasis Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Type (2020-2025)
1.5.2 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Type (2020-2025)
1.5.4 South America Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Monoclonal Antibodies for Plaque Psoriasis Industry Trends
2.2 Monoclonal Antibodies for Plaque Psoriasis Industry Drivers
2.3 Monoclonal Antibodies for Plaque Psoriasis Industry Opportunities and Challenges
2.4 Monoclonal Antibodies for Plaque Psoriasis Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Monoclonal Antibodies for Plaque Psoriasis Revenue (2020-2025)
3.2 Global Top Players by Monoclonal Antibodies for Plaque Psoriasis Sales (2020-2025)
3.3 Global Top Players by Monoclonal Antibodies for Plaque Psoriasis Price (2020-2025)
3.4 Global Monoclonal Antibodies for Plaque Psoriasis Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Monoclonal Antibodies for Plaque Psoriasis Major Company Production Sites & Headquarters
3.6 Global Monoclonal Antibodies for Plaque Psoriasis Company, Product Type & Application
3.7 Global Monoclonal Antibodies for Plaque Psoriasis Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Monoclonal Antibodies for Plaque Psoriasis Market CR5 and HHI
3.8.2 Global Top 5 and 10 Monoclonal Antibodies for Plaque Psoriasis Players Market Share by Revenue in 2024
3.8.3 2023 Monoclonal Antibodies for Plaque Psoriasis Tier 1, Tier 2, and Tier 3
4 Monoclonal Antibodies for Plaque Psoriasis Regional Status and Outlook
4.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Monoclonal Antibodies for Plaque Psoriasis Historic Market Size by Region
4.2.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales in Volume by Region (2020-2025)
4.2.2 Global Monoclonal Antibodies for Plaque Psoriasis Sales in Value by Region (2020-2025)
4.2.3 Global Monoclonal Antibodies for Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Monoclonal Antibodies for Plaque Psoriasis Forecasted Market Size by Region
4.3.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales in Volume by Region (2026-2031)
4.3.2 Global Monoclonal Antibodies for Plaque Psoriasis Sales in Value by Region (2026-2031)
4.3.3 Global Monoclonal Antibodies for Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Monoclonal Antibodies for Plaque Psoriasis by Application
5.1 Monoclonal Antibodies for Plaque Psoriasis Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Application
5.2.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size Overview by Application (2020-2031)
5.2.2 Global Monoclonal Antibodies for Plaque Psoriasis Historic Market Size Review by Application (2020-2025)
5.2.3 Global Monoclonal Antibodies for Plaque Psoriasis Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Application (2020-2025)
5.3.2 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Application (2020-2025)
5.3.4 South America Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 AbbVie, Inc.
6.1.1 AbbVie, Inc. Comapny Information
6.1.2 AbbVie, Inc. Business Overview
6.1.3 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.1.5 AbbVie, Inc. Recent Developments
6.2 Almirall SA
6.2.1 Almirall SA Comapny Information
6.2.2 Almirall SA Business Overview
6.2.3 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.2.5 Almirall SA Recent Developments
6.3 Bausch Health Cos., Inc
6.3.1 Bausch Health Cos., Inc Comapny Information
6.3.2 Bausch Health Cos., Inc Business Overview
6.3.3 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.3.5 Bausch Health Cos., Inc Recent Developments
6.4 Biocon Ltd.
6.4.1 Biocon Ltd. Comapny Information
6.4.2 Biocon Ltd. Business Overview
6.4.3 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.4.5 Biocon Ltd. Recent Developments
6.5 Janssen Biotech, Inc.
6.5.1 Janssen Biotech, Inc. Comapny Information
6.5.2 Janssen Biotech, Inc. Business Overview
6.5.3 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.5.5 Janssen Biotech, Inc. Recent Developments
6.6 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Comapny Information
6.6.2 Sun Pharmaceutical Industries Ltd. Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments
6.7 UCB, Inc.
6.7.1 UCB, Inc. Comapny Information
6.7.2 UCB, Inc. Business Overview
6.7.3 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.7.5 UCB, Inc. Recent Developments
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd
6.8.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Comapny Information
6.8.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Business Overview
6.8.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.8.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments
6.9 Eli Lilly & Co.
6.9.1 Eli Lilly & Co. Comapny Information
6.9.2 Eli Lilly & Co. Business Overview
6.9.3 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.9.5 Eli Lilly & Co. Recent Developments
6.10 Novartis AG
6.10.1 Novartis AG Comapny Information
6.10.2 Novartis AG Business Overview
6.10.3 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.10.5 Novartis AG Recent Developments
6.11 Chongqing Genrix Biopharmaceutical Co., Ltd
6.11.1 Chongqing Genrix Biopharmaceutical Co., Ltd Comapny Information
6.11.2 Chongqing Genrix Biopharmaceutical Co., Ltd Business Overview
6.11.3 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product Portfolio
6.11.5 Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments
7 North America by Country
7.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales by Country
7.1.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (2020-2025)
7.1.3 North America Monoclonal Antibodies for Plaque Psoriasis Sales Forecast by Country (2026-2031)
7.2 North America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
7.2.1 North America Monoclonal Antibodies for Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country (2020-2025)
7.2.3 North America Monoclonal Antibodies for Plaque Psoriasis Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales by Country
8.1.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Monoclonal Antibodies for Plaque Psoriasis Sales by Country (2020-2025)
8.1.3 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Forecast by Country (2026-2031)
8.2 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
8.2.1 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size by Country (2020-2025)
8.2.3 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales by Country
9.1.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales by Country (2020-2025)
9.1.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
9.2.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales by Country
10.1.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Monoclonal Antibodies for Plaque Psoriasis Sales by Country (2020-2025)
10.1.3 South America Monoclonal Antibodies for Plaque Psoriasis Sales Forecast by Country (2026-2031)
10.2 South America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
10.2.1 South America Monoclonal Antibodies for Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country (2020-2025)
10.2.3 South America Monoclonal Antibodies for Plaque Psoriasis Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales by Country
11.1.1 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales by Country (2020-2025)
11.1.3 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
11.2.1 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Monoclonal Antibodies for Plaque Psoriasis Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies for Plaque Psoriasis Value Chain Analysis
12.1.1 Monoclonal Antibodies for Plaque Psoriasis Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Monoclonal Antibodies for Plaque Psoriasis Production Mode & Process
12.2 Monoclonal Antibodies for Plaque Psoriasis Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Monoclonal Antibodies for Plaque Psoriasis Distributors
12.2.3 Monoclonal Antibodies for Plaque Psoriasis Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.